NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Meeting Updates
We refer to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015 and enclose a copy of the Q1 FY 2020-2021 Earnings Call details, for your information and records. NEULAND LABORATORIES LTD. - 524558 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter Ended June 30, 2020
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2020 ,inter alia, to consider and approve We hereby inform you that a meeting of Board of Directors of the Company will be held on Tuesday, August 4, 2020, inter-alia to consider and take on record the unaudited financial results of the Company for the quarter ended June 30, 2020. In continuation to our letter dated June 30, 2020, as per the provisions of the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information of the Company, the trading window for dealing in the securities of the Company for Designated Persons, their immediate relatives and other Insiders, covered in terms of the Company''s Code of Conduct under SEBI (Prohibition of Insider Trading), Regulations, 2015, which was closed from July 1, 2020, shall open after forty-eight hours of declaration of unaudited financial results of the Company for the quarter ended June 30, 2020, to the Stock Exchanges. This is for your information and records. NEULAND LABORATORIES LTD. - 524558 - Shareholding for the Period Ended June 30, 2020
Neuland Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here NEULAND LABORATORIES LTD. - 524558 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed certificate as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2020, received from our Registrar and Share Transfer Agent, KFin Technologies Private Limited. NEULAND LABORATORIES LTD. - 524558 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sarada BhamidipatiDesignation :- Company Secretary and Compliance Officer NEULAND LABORATORIES LTD. - 524558 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Neuland Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here NEULAND LABORATORIES LTD. - 524558 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
With reference to the captioned subject, please find attached the following. 1.Summary of proceedings as required under Regulation 30, Part A of Schedule III of SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015. 2.Voting results as required under Regulation 44 of SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015. 3.Report of Scrutinizer dated July 10, 2020, pursuant to Section 108 of the Companies Act 2013 and Rule 20 (4) (xii) of the Companies (Management and Administration) Rules, 2014. Please take note that the above referred documents are being uploaded on the Website of the company. We request you to take these documents on your records. NEULAND LABORATORIES LTD. - 524558 - Shareholder Meeting / Postal Ballot-Outcome of AGM
With reference to the captioned subject, please find attached the following. 1.Summary of proceedings as required under Regulation 30, Part A of Schedule III of SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015. 2.Voting results as required under Regulation 44 of SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015. 3.Report of Scrutinizer dated July 10, 2020, pursuant to Section 108 of the Companies Act 2013 and Rule 20 (4) (xii) of the Companies (Management and Administration) Rules, 2014. Please take note that the above referred documents are being uploaded on the Website of the company. We request you to take these documents on your records. NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper Publication regarding the equity shares liable to be transferred to the Investor Education and Protection Fund pursuant to Section 124(6) of the Companies Act, 2013 read with Rule 6 of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016. NEULAND LABORATORIES LTD. - 524558 - Closure of Trading Window
The trading window for dealing in the equity shares of the Company shall remain closed from July 1, 2020 till 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2020, to the stock exchanges, for the Designated Persons, their immediate relatives and other Insiders of the Company as covered under the Company''s Code of Conduct. The date of Board Meeting of the Company for the consideration of the unaudited financial results for the quarter ended June 30, 2020 shall be intimated in due course.